Seah LIm
Fortuna: 41 474 $ al 30/06/2026
Fortuna: 41 474 $ al 30/06/2026
Seah H.
LIm is the founder of Medicovestor, Inc. Currently, Dr. LIm is the Director of the Adult Sickle Cell Program at SUNY Upstate Medical University since 2021.
Formerly, Dr. LIm was the Chief Executive Officer of Medicovestor Bio Plc and served as an Independent Director at Emmaus Life Sciences, Inc. from 2022 to 2024.
Dr. LIm earned doctorates from the University of Aberdeen and The University of Wales.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/03/2025 | 4.147.426 ( 5,91 % ) | 41 474 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
SUNY Upstate Medical University
SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/10/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| EMMAUS LIFE SCIENCES, INC. | Director/Miembro de la Junta | 04/11/2024 |
Medicovestor Bio Plc | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
University of Aberdeen
University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SUNY Upstate Medical University
SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Wales
The University of Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Health Technology |
Medicovestor Bio Plc |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.